methyl (2S,3R)-3-cyclopropyl-3-(3-hydroxy-4-iodophenyl)-2-methylpropanoate, 98%, 1g

Methyl 4-Formyl-3-nitrobenzoate>98.0%(GC)1g

1-(2,4-Difluorophenyl)-N-methylmethanamine, 95.0%, 1g

bScope BS.1153-EPLPHi for phase contrast. Triocular with HWF 10x/20 mm eyepieces and quintuple revolver E-plan Phase IOS 10/20/S40 S100x

4-(4H-1,2,4-Triazol-4-yl)piperidine, 95.0%, 5g

2-Chloro-4-methoxy-6-methyl-pyrimidine, 95.0%, 5g

5-Bromo-1H-pyrrolo[2,3-b]pyridin-4-amine, 95.0%, 5g

Na-Boc-Ng-(2,4-dinitrophenyl)-L-2,4-diaminobutyric acid, 98.0%, 250mg

4-Bromo-2,3,5,6-tetrafluorobenzaldehyde, 95.0%, 250mg

BENZYL 3-(METHYLAMINO)AZETIDINE-1-CARBOXYLATE, 95.0%, 10g

N,N-Dimethyl-1H-indazol-5-amine, 95.0%, 250mg

4-Aminophthalonitrile, 95.0%, 5g

1-(3-Ethylphenyl)ethanone, 95.0%, 100g